Lingyun Lan

625 total citations
6 papers, 493 citations indexed

About

Lingyun Lan is a scholar working on Cancer Research, Oncology and Biomedical Engineering. According to data from OpenAlex, Lingyun Lan has authored 6 papers receiving a total of 493 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Cancer Research, 2 papers in Oncology and 2 papers in Biomedical Engineering. Recurrent topics in Lingyun Lan's work include Cancer, Hypoxia, and Metabolism (4 papers), Nanoplatforms for cancer theranostics (2 papers) and Neuroblastoma Research and Treatments (1 paper). Lingyun Lan is often cited by papers focused on Cancer, Hypoxia, and Metabolism (4 papers), Nanoplatforms for cancer theranostics (2 papers) and Neuroblastoma Research and Treatments (1 paper). Lingyun Lan collaborates with scholars based in United States and New Zealand. Lingyun Lan's co-authors include Charles P. Hart, Jianxin Duan, Monica Banica, Gustavo Lorente, James Evans, Mark Matteucci, Fanying Meng, Xiaohong Cai, Timothy F. Stanton and W. S. Ammons and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Journal of Medicinal Chemistry.

In The Last Decade

Lingyun Lan

6 papers receiving 469 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingyun Lan United States 5 242 181 174 145 81 6 493
Bylgja Hilmarsdóttir Iceland 15 228 0.9× 366 2.0× 218 1.3× 64 0.4× 18 0.2× 24 573
Naomi Laing United States 18 130 0.5× 367 2.0× 454 2.6× 182 1.3× 34 0.4× 31 804
Yinxing Zhu China 12 126 0.5× 209 1.2× 242 1.4× 163 1.1× 14 0.2× 31 543
Xiaofen Pan China 15 131 0.5× 330 1.8× 107 0.6× 170 1.2× 102 1.3× 35 706
William Sutherland United States 5 309 1.3× 190 1.0× 361 2.1× 216 1.5× 39 0.5× 11 665
Paul Crea Australia 12 265 1.1× 531 2.9× 367 2.1× 152 1.0× 24 0.3× 27 872
Young‐Kwang Yoon South Korea 13 104 0.4× 412 2.3× 442 2.5× 203 1.4× 28 0.3× 22 736
Yuki Abe Japan 10 61 0.3× 281 1.6× 892 5.1× 296 2.0× 38 0.5× 25 1.1k
Alexandr Kristian Norway 13 181 0.7× 288 1.6× 276 1.6× 116 0.8× 12 0.1× 24 641
Vincent A. de Weger Netherlands 11 67 0.3× 211 1.2× 334 1.9× 94 0.6× 38 0.5× 26 551

Countries citing papers authored by Lingyun Lan

Since Specialization
Citations

This map shows the geographic impact of Lingyun Lan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingyun Lan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingyun Lan more than expected).

Fields of papers citing papers by Lingyun Lan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingyun Lan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingyun Lan. The network helps show where Lingyun Lan may publish in the future.

Co-authorship network of co-authors of Lingyun Lan

This figure shows the co-authorship network connecting the top 25 collaborators of Lingyun Lan. A scholar is included among the top collaborators of Lingyun Lan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingyun Lan. Lingyun Lan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Meng, Fanying, James Evans, Monica Banica, et al.. (2011). Molecular and Cellular Pharmacology of the Hypoxia-Activated Prodrug TH-302. Molecular Cancer Therapeutics. 11(3). 740–751. 160 indexed citations
2.
Poultsides, George A., Lyen C. Huang, John L. Cameron, et al.. (2011). Duodenal Adenocarcinoma: Clinicopathologic Analysis and Implications for Treatment. Annals of Surgical Oncology. 19(6). 1928–1935. 94 indexed citations
3.
Hart, Charles P., Fanying Meng, Monica Banica, et al.. (2008). In vitro activity profile of the novel hypoxia-activated cytotoxic prodrug TH-302. Cancer Research. 68. 1441–1441. 1 indexed citations
4.
Duan, Jianxin, Jacob A. Kaizerman, Timothy F. Stanton, et al.. (2008). Potent and Highly Selective Hypoxia-Activated Achiral Phosphoramidate Mustards as Anticancer Drugs. Journal of Medicinal Chemistry. 51(8). 2412–2420. 188 indexed citations
5.
Duan, Jianxin, Xiaohong Cai, Fanying Meng, et al.. (2007). Potent Antitubulin Tumor Cell Cytotoxins Based on 3-Aroyl Indazoles. Journal of Medicinal Chemistry. 50(5). 1001–1006. 46 indexed citations
6.
Hart, Charles P., Don Jung, Haiyan Jiao, et al.. (2007). Discovery of TH-302: An achiral hypoxia-activated cytotoxic prodrug. Journal of Clinical Oncology. 25(18_suppl). 3515–3515. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026